Statistical Review of Animal trials – A Guideline

10/29/2021
by   Sophie K. Piper, et al.
0

Examinations of any experiment involving living organisms require justifications of the need and moral defensibleness of the study. Statistical planning, design and sample size calculation of the experiment are no less important review criteria than general medical and ethical points to consider. Errors made in the statistical planning and data evaluation phase can have severe consequences on both results and conclusions. They might proliferate and thus impact future trials-an unintended outcome of fundamental research with profound ethical consequences. Therefore, any trial must be efficient in both a medical and statistical way in answering the questions of interests to be considered as approvable. Unified statistical standards are currently missing for animal review boards in Germany. In order to accompany, we developed a biometric form to be filled and handed in with the proposal at the local authority on animal welfare. It addresses relevant points to consider for biostatistical planning of animal experiments and can help both the applicants and the reviewers in overseeing the entire experiment(s) planned. Furthermore, the form might also aid in meeting the current standards set by the 3+3R's principle of animal experimentation Replacement, Reduction, Refinement as well as Robustness, Registration and Reporting. The form has already been in use by the local authority of animal welfare in Berlin, Germany. In addition, we provide reference to our user guide giving more detailed explanation and examples for each section of the biometric form. Unifying the set of biostatistical aspects will help both the applicants and the reviewers to equal standards and increase quality of preclinical research projects, also for translational, multicenter, or international studies.

READ FULL TEXT
research
07/17/2021

Assessing Support for Industry Standards in Reference Medical Software Architectures

Industrial standards for developing medical device software provide requ...
research
11/27/2020

Design aspects of COVID-19 treatment trials: Improving probability and time of favourable events

As a reaction to the pandemic of the severe acute respiratory syndrome c...
research
08/12/2022

Statistical analyses of ordinal outcomes in randomised controlled trials: protocol for a scoping review

Randomised controlled trials aim to assess the impact of one (or more) h...
research
01/13/2023

Designing translational animal experiments by Bayesian MAP approaches

The planning and conduct of animal experiments in the European Union is ...
research
11/21/2020

Human computation requires and enables a new approach to ethical review

With humans increasingly serving as computational elements in distribute...
research
01/11/2023

Pragmatic Estimation of Sample Size for Number of Interviews for PRO development in the 2009 FDA PRO guidance

PROs developed de novo, using the FDA guidance may involve structured pa...

Please sign up or login with your details

Forgot password? Click here to reset